Replies to post #192586 on Biotech Values

[DewDiligence]

EXAS forecasts 21K completed Cologuard tests during 2Q15 (vs 11K in 1Q15) and 32K completed tests in 3Q15:

http://finance.yahoo.com/news/exact-sciences-provides-strong-launch-103000250.html

This PR was released in conjunction with today’s Investor Day webcast.